J&J inks a $1.15B discovery deal with PeptiDream; Medivir plots PhIII HDAC program
→ Tokyo-based PeptiDream has struck a discovery deal with J&J worth up to $1.15 billion. In the deal PeptiDream will use its platform tech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
